Literature DB >> 4864652

The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism.

G J Brewer, C J Zarafonetis.   

Abstract

In view of the fact that increased resistance to drugs by malaria parasites in some parts of the world may lead to increasing use of a combination of primaquine with chloroquine for chemotherapy, studies were made on the severity of the haemolytic anaemia induced by 45 mg primaquine in American Negroes with glucose-6-phosphate dehydrogenase deficiency. It was found that twice-weekly administration of primaquine induced more haemolysis than once-weekly administration, and that administration once weekly for 4 weeks and twice weekly thereafter resulted in a degree of anaemia falling between those produced by the other regimens. Anaemia was not induced in controls with no G6PD deficiency. One volunteer developed an intercurrent infection that was treated with salicylates; his haemolysis was markedly intensified, but whether by the infection, the salicylates or both could not be determined.In a conjoint study, the administration of six malaria-suppressive drugs had no detectable effect on the activities of several erythrocyte enzymes or on the levels of adenosine monophosphate, diphosphate or triphosphate.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4864652      PMCID: PMC2476383     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM COLOMBIA, SOUTH AMERICA.

Authors:  R D POWELL; G J BREWER; A S ALVING
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

2.  The tolerance to large weekly doses of primaquine and amodiaquine in primaquine-sensitive and non-sensitive subjects.

Authors:  M M CAHN; E J LEVY
Journal:  Am J Trop Med Hyg       Date:  1962-09       Impact factor: 2.345

3.  RELATIONSHIP BETWEEN ACTIVITY OF PYRUVATE KINASE AND AGE OF THE NORMAL HUMAN ERYTHROCYTE.

Authors:  R D POWELL; R L DEGOWIN
Journal:  Nature       Date:  1965-01-30       Impact factor: 49.962

4.  Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia.

Authors:  K R TANAKA; W N VALENTINE; S MIWA
Journal:  Blood       Date:  1962-03       Impact factor: 22.113

5.  Chloroquine resistance in Plasmodium falciparum.

Authors:  M D YOUNG; D V MOORE
Journal:  Am J Trop Med Hyg       Date:  1961-05       Impact factor: 2.345

6.  The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes.

Authors:  R W KELLERMEYER; A R TARLOV; S L SCHRIER; P E CARSON; A S ALVING
Journal:  J Lab Clin Med       Date:  1961-08

7.  Further studies on the properties and assay of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of rat liver.

Authors:  G E GLOCK; P McLEAN
Journal:  Biochem J       Date:  1953-10       Impact factor: 3.857

8.  A study of the relationship between the content of adenosine triphosphate in human red cells and the course of falciparum malaria: a new system that may confer protection against malaria.

Authors:  G J Brewer; R D Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

9.  The adenosine triphosphate content of glucose-6-phosphate dehydrogenase-deficient and normal erythrocytes, including studies of a glucose-6-phosphate dehydrogenase-deficient man with "elevated erythrocytic ATP".

Authors:  G J Brewer; R D Powell
Journal:  J Lab Clin Med       Date:  1966-05

10.  STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM.

Authors:  R D POWELL; G J BREWER; R L DEGOWIN; A S ALVING
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

View more
  10 in total

Review 1.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 2.  Primaquine in vivax malaria: an update and review on management issues.

Authors:  Deepika Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  Malar J       Date:  2011-12-12       Impact factor: 2.979

3.  In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.

Authors:  Seif A Shekalaghe; Roel ter Braak; Modibo Daou; Reginald Kavishe; Wouter van den Bijllaardt; Sven van den Bosch; Jan B Koenderink; Adrian J F Luty; Christopher J M Whitty; Chris Drakeley; Robert W Sauerwein; Teun Bousema
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

Review 4.  Advances in the Pharmacogenomics of Adverse Drug Reactions.

Authors:  Susannah L Collins; Daniel F Carr; Munir Pirmohamed
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

5.  Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations.

Authors:  Biljana Stanković; Nikola Kotur; Vladimir Gašić; Kristel Klaassen; Bojan Ristivojević; Maja Stojiljković; Sonja Pavlović; Branka Zukić
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

Review 6.  Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.

Authors:  Nicholas J White; Li Guo Qiao; Gao Qi; Lucio Luzzatto
Journal:  Malar J       Date:  2012-12-14       Impact factor: 2.979

Review 7.  The medication for pneumocystis pneumonia with glucose-6-phosphate dehydrogenase deficiency patients.

Authors:  Ziyu Zhang; Qinhui Li; Xiaoyan Shen; Lankai Liao; Xia Wang; Min Song; Xi Zheng; Yulian Zhu; Yong Yang
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

8.  Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae.

Authors:  Kevin C Kobylinski; Brian D Foy; Jason H Richardson
Journal:  Malar J       Date:  2012-11-21       Impact factor: 2.979

9.  A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.

Authors:  Toby Leslie; Ismail Mayan; Nasir Mohammed; Panna Erasmus; Jan Kolaczinski; Christopher J M Whitty; Mark Rowland
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency.

Authors:  Duangdao Nantakomol; Rick Paul; Attakorn Palasuwan; Nicholas P J Day; Nicholas J White; Mallika Imwong
Journal:  Malar J       Date:  2013-08-21       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.